查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1855958

2025年全球息肉切片检查市场报告

Polyp Biopsy Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，息肉切片检查市场规模呈现强劲成长，从2024年的12.7亿美元成长到2025年的13.9亿美元，复合年增长率达8.7%。这一增长可归因于人们对结直肠癌筛检意识的提高、胃肠道疾病盛行率的上升、医院和诊断基础设施的扩建、政府资助的筛检计画以及切片检查钳技术的进步。

预计未来几年息肉切片检查市场规模将维持强劲成长，2029年将达到19.1亿美元，复合年增长率（CAGR）为8.3%。预测期内的成长主要受以下因素驱动：对微创手术的需求不断增长、一次性切片检查器械的普及、医疗保健行业对癌症早期检测的投入增加、诊断程序保险覆盖范围扩大以及全球人口老龄化导致筛检率上升。预测期内的关键趋势包括：人工智慧在切片检查分析中的应用、机器人辅助切片检查技术的开发、一次性器械使用量的增加、对门诊和流动医疗中心的偏好，以及向个人化医疗和精准诊断的转变。

大肠直肠癌发生率的不断上升预计将显着推动息肉切片检查市场的发展。大肠直肠癌是一种恶性肿瘤，由于大肠内壁上皮细胞异常且不受控制地增生，导致结肠或直肠发生癌变。这种癌症的特征是能够侵袭邻近组织并转移至身体其他部位。大肠直肠癌病例的增加很大程度上归因于常见的饮食习惯，例如高加工食品摄取量和低膳食纤维摄取量。这些饮食习惯会导致慢性炎症，破坏肠道菌群，并促进癌前病变的形成，最终发展为癌症。息肉切片检查在应对这一趋势中发挥关键作用，它有助于早期发现异常病变并进行组织学检查，从而实现及时治疗并降低疾病进展的风险。例如，总部位于美国的非营利组织美国癌症协会估计，到2025年，美国将新增107,320例结肠癌病例和46,950例直肠癌病例，导致约52,900人死亡。因此，大肠直肠癌发生率的上升正在推动息肉切片检查手术的需求。

息肉切片检查市场的主要企业正在投资先进技术，例如人工智慧辅助检测系统，以提高结肠息肉的识别率，并实现对潜在癌症病变的早期发现。人工智慧辅助检测系统是一种医疗工具，它能够即时评估影像数据，检测异常情况，并为医疗专业人员产生视觉警报，从而在不进行治疗方法的情况下支援临床决策。例如，2024年9月，总部位于美国的医疗技术公司Odin Medical Ltd.与Olympus Corporation合作推出了CADDIE，云端基础的人工智慧内视镜平台。 CADDIE系统能够即时分析大肠镜检查影像，识别潜在的大肠息肉部位，从而帮助临床医生在检查过程中做出更明智的决策。临床评估表明，该系统在不增加检查时间或风险的情况下提高了腺瘤检出率，证明了其在支持早期诊断和改善患者照护的有效性。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球息肉切片检查：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球息肉切片检查市场：成长率分析
  • 全球息肉切片检查市场表现：规模与成长，2019-2024年
  • 全球息肉切片检查市场预测：规模与成长，2024-2029年，2034年
  • 全球息肉切片检查：潜在市场规模 (TAM)

第六章 市场细分

  • 全球息肉切片检查市场按类型、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 大肠镜检查
  • 阴道镜直接切片检查
  • 食道胃十二指肠镜检查
  • 喉镜检查
  • 全球息肉切片检查市场：依技术、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 内视镜黏膜切除术（EMR）
  • 内视镜黏膜下剥离术（ESD）
  • 常规切片检查
  • 全球息肉切片检查市场依通路划分：绩效及预测，2019-2024年、2024-2029年、2034年
  • 线上销售管道
  • 零售药房
  • 其他分销管道
  • 全球息肉切片检查市场：按应用、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 大肠直肠癌
  • 胃肠道疾病
  • 其他用途
  • 全球息肉切片检查市场按最终用户、性能和预测划分，2019-2024年、2024-2029年、2034年
  • 医院
  • 诊断实验室
  • 专科诊所
  • 全球息肉切片检查市场：按大肠镜检查、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 诊断性大肠镜检查
  • 筛检肠镜检查
  • 治疗性大肠镜检查
  • 虚拟大肠镜检查
  • 全球息肉切片检查市场：按阴道镜和直接切片检查细分，按类型、性能和预测（2019-2024年、2024-2029年、2034年）
  • 子宫颈切片检查
  • 切片检查
  • 切片检查
  • 肛门切片检查
  • 全球息肉切片检查市场：按食道胃十二指肠镜检查、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 诊断性食道胃十二指肠镜检查
  • 治疗性食道胃十二指肠镜检查
  • 监测性食道胃十二指肠镜检查
  • 食道胃十二指肠镜筛检
  • 全球息肉切片检查市场：按喉镜检查、类型、性能和预测进行细分，2019-2024年、2024-2029年、2034年
  • 直接喉镜检查
  • 间接喉镜检查
  • 柔性喉镜检查
  • 硬式喉镜检查

第七章 区域和国家分析

  • 全球息肉切片检查市场：区域表现及预测，2019-2024年、2024-2029年及2034年
  • 全球息肉切片检查市场：按国家/地区、绩效和预测划分，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 息肉切片检查市场：竞争格局
  • 息肉切片检查市场：公司概况
    • Johnson & Johnson（Ethicon）Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Becton Dickinson and Company（BD）
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Olympus Corporation
  • STERIS plc
  • Hologic Inc.
  • CooperSurgical Inc.
  • KARL STORZ SE & Co. KG
  • Cook Medical
  • ConMed Corporation
  • Ambu A/S
  • Richard Wolf GmbH
  • INRAD
  • Acheron Instruments（Pvt）Ltd.
  • Innovia Medical

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年息肉切片检查市场：提供新机会的国家
  • 息肉切片检查市场展望（2029）：新兴细分市场机会
  • 息肉切片检查市场展望（2029）：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r38610

A polyp biopsy is a medical procedure in which a healthcare professional removes a small tissue sample from an abnormal growth, or polyp, on the lining of an organ or body cavity. The sample is examined under a microscope to assess cellular characteristics, detect disease, and support accurate diagnosis and treatment planning. This procedure helps determine the nature of polyps, distinguish between benign and malignant conditions, and provide critical information for guiding clinical management or surveillance strategies.

The primary types of polyp biopsy are colonoscopy, colposcopy-directed biopsy, esophagogastroduodenoscopy, and laryngoscopy. Colonoscopy with polyp biopsy involves inserting a flexible camera (colonoscope) into the colon to visualize the intestinal lining and remove tissue samples for diagnostic evaluation. Techniques include endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and conventional biopsy. These procedures are distributed through online channels, retail pharmacies, and other outlets, and are applied in areas such as colorectal cancer and gastrointestinal disorders. End-users include hospitals, diagnostic laboratories, and specialty clinics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The polyp biopsy market research report is one of a series of new reports from The Business Research Company that provides polyp biopsy market statistics, including polyp biopsy industry global market size, regional shares, competitors with a polyp biopsy market share, detailed polyp biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the polyp biopsy industry. This polyp biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polyp biopsy market size has grown strongly in recent years. It will grow from $1.27 billion in 2024 to $1.39 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period is attributed to increasing awareness of colorectal cancer screening, rising prevalence of gastrointestinal disorders, expansion of hospital and diagnostic infrastructure, government-supported screening programs, and technological advancements in biopsy forceps.

The polyp biopsy market size is expected to see strong growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period is driven by rising demand for minimally invasive procedures, increased adoption of disposable biopsy devices, healthcare investments in early cancer detection, expanding insurance coverage for diagnostic procedures, and an aging global population boosting screening rates. Key trends in the forecast period include the integration of artificial intelligence in biopsy analysis, development of robotic-assisted biopsy procedures, growing use of disposable and single-use devices, preference for outpatient and ambulatory care centers, and a shift toward personalized medicine and precision diagnostics.

The growing prevalence of colorectal cancer is expected to contribute significantly to the expansion of the polyp biopsy market. Colorectal cancer is a malignant condition that develops in the colon or rectum, originating from abnormal and uncontrolled growth of epithelial cells lining the large intestine. This form of cancer is known for its ability to invade nearby tissues and spread to other parts of the body. The increase in colorectal cancer cases is largely attributed to common dietary habits that are high in processed foods and low in fiber. These habits can cause chronic inflammation, disrupt gut microbiota, and encourage the formation of precancerous growths that may eventually become cancerous. Polyp biopsy plays a critical role in addressing this trend by facilitating early detection and histological examination of abnormal lesions, thereby enabling timely treatment and reducing the risk of disease progression. For example, in 2025, the American Cancer Society, a nonprofit organization based in the United States, estimated that there would be 107,320 new cases of colon cancer and 46,950 new cases of rectal cancer in the country, with approximately 52,900 deaths expected as a result. As such, the rising incidence of colorectal cancer is fueling demand for polyp biopsy procedures.

Key companies in the polyp biopsy market are investing in advanced technologies such as artificial intelligence-assisted detection systems to improve the identification of colorectal polyps and enable earlier recognition of potentially cancerous lesions. An artificial intelligence-assisted detection system is a medical tool that evaluates imaging data in real time to detect abnormalities and generate visual alerts for healthcare providers, assisting them in making informed clinical decisions without delivering therapeutic treatments. For example, in September 2024, Odin Medical Ltd., a medical technology firm based in the United States and affiliated with Olympus Corporation, introduced CADDIE, a cloud-based artificial intelligence endoscopy platform. The CADDIE system analyzes colonoscopy footage in real time, identifying areas that may contain colorectal polyps and allowing clinicians to make better decisions during the examination. Clinical evaluations showed that the system improves the rate of adenoma detection without increasing the time or risk involved in the procedure, demonstrating its effectiveness in supporting early diagnosis and improving patient care.

In October 2024, Caldera Medical, a medical device manufacturer based in the United States, acquired UVision360, Inc. for an undisclosed amount. Through this acquisition, Caldera Medical gains access to UVision360's advanced hysteroscopy technology, including the LUMINELLE Bx system, which enhances the company's offerings in minimally invasive diagnostic and treatment options for uterine conditions such as polyps, fibroids, and other intrauterine abnormalities. UVision360 is a company based in the United States that develops hysteroscopy and cystoscopy systems, including the LUMINELLE platform.

Major players in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., Cooper Surgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical.

North America was the largest region in the polyp biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in polyp biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the polyp biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polyp biopsy market consists of revenues earned by entities by providing services such as endoscopic ultrasound (EUS), capsule endoscopy, double-balloon enteroscopy, single-balloon enteroscopy, push enteroscopy, transnasal endoscopy, and transanal endoscopic microsurgery (TEM). The market value includes the value of related goods sold by the service provider or included within the service offering. The polyp biopsy market also includes sales of hot biopsy forceps, cold biopsy forceps, endoscopic snares, polypectomy snares, cytology brushes, biopsy needles (fine-needle aspiration needles, core biopsy needles), and endoscopic ultrasound needles. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polyp Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polyp biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polyp biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polyp biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Colonoscopy; Colposcopy-Directed Biopsy; Esophagogastroduodenoscopy; Laryngoscopy
  • 2) By Technique: Endoscopic Mucosal Resection (EMR); Endoscopic Submucosal Dissection (ESD); Conventional Biopsy
  • 3) By Distribution Channel: Online Sales Channels; Retail Pharmacies; Other Distribution Channels
  • 4) By Application: Colorectal Cancer; Gastrointestinal Disorders; Other Applications
  • 5) By End-User: Hospitals; Diagnostic Laboratories; Specialty Clinics
  • Subsegments:
  • 1) By Colonoscopy: Diagnostic Colonoscopy; Screening Colonoscopy; Therapeutic Colonoscopy; Virtual Colonoscopy
  • 2) By Colposcopy-Directed Biopsy: Cervical Biopsy; Vaginal Biopsy; Vulvar Biopsy; Anal Biopsy
  • 3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy; Therapeutic Esophagogastroduodenoscopy; Surveillance Esophagogastroduodenoscopy; Screening Esophagogastroduodenoscopy
  • 4) By Laryngoscopy: Direct Laryngoscopy; Indirect Laryngoscopy; Flexible Laryngoscopy; Rigid Laryngoscopy
  • Companies Mentioned: Johnson & Johnson (Ethicon); Medtronic plc; Medline Industries LP; FUJIFILM Holdings Corporation; Stryker Corporation; Becton Dickinson and Company (BD); Boston Scientific Corporation; B. Braun Melsungen AG; Olympus Corporation; STERIS plc; Hologic Inc.; CooperSurgical Inc.; KARL STORZ SE & Co. KG; Cook Medical; ConMed Corporation; Ambu A/S; Richard Wolf GmbH; INRAD; Acheron Instruments (Pvt) Ltd.; Innovia Medical
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polyp Biopsy Market Characteristics

3. Polyp Biopsy Market Trends And Strategies

4. Polyp Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Polyp Biopsy Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Polyp Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Polyp Biopsy Market Growth Rate Analysis
  • 5.4. Global Polyp Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Polyp Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Polyp Biopsy Total Addressable Market (TAM)

6. Polyp Biopsy Market Segmentation

  • 6.1. Global Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colonoscopy
  • Colposcopy-Directed Biopsy
  • Esophagogastroduodenoscopy
  • Laryngoscopy
  • 6.2. Global Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endoscopic Mucosal Resection (EMR)
  • Endoscopic Submucosal Dissection (ESD)
  • Conventional Biopsy
  • 6.3. Global Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Online Sales Channels
  • Retail Pharmacies
  • Other Distribution Channels
  • 6.4. Global Polyp Biopsy Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Colorectal Cancer
  • Gastrointestinal Disorders
  • Other Applications
  • 6.5. Global Polyp Biopsy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Specialty Clinics
  • 6.6. Global Polyp Biopsy Market, Sub-Segmentation Of Colonoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Colonoscopy
  • Screening Colonoscopy
  • Therapeutic Colonoscopy
  • Virtual Colonoscopy
  • 6.7. Global Polyp Biopsy Market, Sub-Segmentation Of Colposcopy-Directed Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cervical Biopsy
  • Vaginal Biopsy
  • Vulvar Biopsy
  • Anal Biopsy
  • 6.8. Global Polyp Biopsy Market, Sub-Segmentation Of Esophagogastroduodenoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Esophagogastroduodenoscopy
  • Therapeutic Esophagogastroduodenoscopy
  • Surveillance Esophagogastroduodenoscopy
  • Screening Esophagogastroduodenoscopy
  • 6.9. Global Polyp Biopsy Market, Sub-Segmentation Of Laryngoscopy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Laryngoscopy
  • Indirect Laryngoscopy
  • Flexible Laryngoscopy
  • Rigid Laryngoscopy

7. Polyp Biopsy Market Regional And Country Analysis

  • 7.1. Global Polyp Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Polyp Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polyp Biopsy Market

  • 8.1. Asia-Pacific Polyp Biopsy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polyp Biopsy Market

  • 9.1. China Polyp Biopsy Market Overview
  • 9.2. China Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polyp Biopsy Market

  • 10.1. India Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polyp Biopsy Market

  • 11.1. Japan Polyp Biopsy Market Overview
  • 11.2. Japan Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polyp Biopsy Market

  • 12.1. Australia Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polyp Biopsy Market

  • 13.1. Indonesia Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polyp Biopsy Market

  • 14.1. South Korea Polyp Biopsy Market Overview
  • 14.2. South Korea Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polyp Biopsy Market

  • 15.1. Western Europe Polyp Biopsy Market Overview
  • 15.2. Western Europe Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polyp Biopsy Market

  • 16.1. UK Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polyp Biopsy Market

  • 17.1. Germany Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polyp Biopsy Market

  • 18.1. France Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polyp Biopsy Market

  • 19.1. Italy Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polyp Biopsy Market

  • 20.1. Spain Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polyp Biopsy Market

  • 21.1. Eastern Europe Polyp Biopsy Market Overview
  • 21.2. Eastern Europe Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polyp Biopsy Market

  • 22.1. Russia Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polyp Biopsy Market

  • 23.1. North America Polyp Biopsy Market Overview
  • 23.2. North America Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polyp Biopsy Market

  • 24.1. USA Polyp Biopsy Market Overview
  • 24.2. USA Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polyp Biopsy Market

  • 25.1. Canada Polyp Biopsy Market Overview
  • 25.2. Canada Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polyp Biopsy Market

  • 26.1. South America Polyp Biopsy Market Overview
  • 26.2. South America Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polyp Biopsy Market

  • 27.1. Brazil Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polyp Biopsy Market

  • 28.1. Middle East Polyp Biopsy Market Overview
  • 28.2. Middle East Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polyp Biopsy Market

  • 29.1. Africa Polyp Biopsy Market Overview
  • 29.2. Africa Polyp Biopsy Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Polyp Biopsy Market, Segmentation By Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Polyp Biopsy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polyp Biopsy Market Competitive Landscape And Company Profiles

  • 30.1. Polyp Biopsy Market Competitive Landscape
  • 30.2. Polyp Biopsy Market Company Profiles
    • 30.2.1. Johnson & Johnson (Ethicon) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medline Industries LP Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. FUJIFILM Holdings Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Polyp Biopsy Market Other Major And Innovative Companies

  • 31.1. Becton Dickinson and Company (BD)
  • 31.2. Boston Scientific Corporation
  • 31.3. B. Braun Melsungen AG
  • 31.4. Olympus Corporation
  • 31.5. STERIS plc
  • 31.6. Hologic Inc.
  • 31.7. CooperSurgical Inc.
  • 31.8. KARL STORZ SE & Co. KG
  • 31.9. Cook Medical
  • 31.10. ConMed Corporation
  • 31.11. Ambu A/S
  • 31.12. Richard Wolf GmbH
  • 31.13. INRAD
  • 31.14. Acheron Instruments (Pvt) Ltd.
  • 31.15. Innovia Medical

32. Global Polyp Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polyp Biopsy Market

34. Recent Developments In The Polyp Biopsy Market

35. Polyp Biopsy Market High Potential Countries, Segments and Strategies

  • 35.1 Polyp Biopsy Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Polyp Biopsy Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Polyp Biopsy Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer